Xcout Intel
One Biosciences
One Biosciences is a biotechnology company headquartered in Paris, France. It is driven by innovative scientists and biotech leaders focused on advancing precision medicine and novel therapies for patients.
Subscribe to see One Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
One Biosciences at a glance
One Biosciences is a biotechnology company headquartered in France. Its most recent funding round, seed, raised $15M in July 2025. Xcout tracks 14 named people at One Biosciences, including Hedi Ben Brahim (CEO).
One Biosciences leadership
- Hedi Ben BrahimCEO
- Vikas AhujaChief Business Officer
- Vincent MillerExecutive Chairman
- Céline VallotCo-Founder
- Eric LetouzéHead of Single-Cell
- Juliette BertorelloHead of Wetlab
8 more named people on record for One Biosciences, with roles, board committees and tenure — see the full roster →
One Biosciences funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| seed | $15M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
One Biosciences competitors
A few of One Biosciences's closest competitors — see the full list of competitors and alternatives →
Oncodesign Precision Medicine is a biopharmaceutical company that develops innovative therapeutic and diagnostic solutions targeting treatment resistance, metastasis, and diseases such as oncology, inflammatory bowel disease, and Parkinson's disease. Utilizing proprietary technologies like OncoSNIPER, Nanocyclix, and PROMETHE, the company advances first-in-class and best-in-class precision medicine programs to serve patients, clinicians, and pharmaceutical partners.
Tyra Biosciences is a biotechnology company headquartered in Carlsbad, California, that develops next-generation precision medicines.
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Hummingbird Bioscience is a precision biotherapeutics company located in Singapore. It focuses on discovering and developing engineered precision biotherapeutics to define the future of precision medicine.
OneChain Immunotherapeutics is a biotechnology company based in Barcelona focused on the development of CAR-T cell therapies and in vivo platforms for cancer immunotherapy.
Coave Therapeutics is a clinical-stage biotechnology company headquartered in Paris, France. The company focuses on developing life-changing gene therapies targeting rare ocular and central nervous system diseases.
Get One Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on One Biosciences in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access